logo-loader
AIM:OPTI

OptiBiotix Health PLC

Receive alerts
Market:
AIM
Market Cap:
£46.61 m
Price
53.00 GBX
Change
-3.64%
52 weeks high
72.70
52 weeks low
23.20

In brief

OptiBiotix Health PLC is a life sciences company operating in one of the most progressive areas of biotechnological research.

Developing technologies that modulate the human microbiome – the collective genome of the microbes in the body – OptiBiotix identifies and develops microbial strains, compounds and formulations for use in food ingredients, supplements and active compounds that can impact on human physiology, deriving potential health benefits.

With an established pipeline of microbiome modulators, the OptiBiotix team works today in the prevention and management of chronic lifestyle diseases including obesity, hypercholesterolemia and lipid profiles, and diabetes.

Deep dive We explore the investor case for growth companies

Snapshot

  • Developer of technologies that modulate the human microbiome 
  • Targeting weight management and chronic lifestyle diseases
  • Existing deals expanded after Wellbiome launch

Insight Widest with the analysis, Proactive gives perspectives that others don't.

SkinBioTherapeutics targets the promising skin microbiome market

The life sciences firm studies how to enhance and reintroduce the good bacteria on the skin

3 weeks, 4 days ago